Medical Economics December 14, 2023
Prescription drug prices, vaccine costs are also key issues.
Pharmacy benefit managers (PBMs) need to shape up their act in the health care market, according to top leaders of the U.S. Centers for Medicare & Medicaid Services (CMS).
PBMs must stop practices “that threaten the sustainability of many pharmacies, impede access to care, and put increased burden on health care providers,” said a Dec. 14, 2023, open letter from CMS Administrator Chiquita Brooks-LaSure and her chief deputy administrators.
“This is especially important for vaccines and treatments that can prevent and treat influenza, COVID-19, and RSV as we enter the winter respiratory virus season,” the letter said.
Prescription drug prices and PBMs have become focal points for scrutiny of the U.S....